[
  {
    "ts": null,
    "headline": "Gilead Buys $20.1 Million of Assembly Biosciences Stock",
    "summary": "Gilead Sciences bought nearly 950,000 more shares of antiviral-therapeutics developer Assembly as part of an amended investment and funding pact.",
    "url": "https://finnhub.io/api/news?id=2ba4f2fb25dc0595b874194d6778bac09e387383bd9b633b9c73506c5c2277ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735459200,
      "headline": "Gilead Buys $20.1 Million of Assembly Biosciences Stock",
      "id": 132195205,
      "image": "",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences bought nearly 950,000 more shares of antiviral-therapeutics developer Assembly as part of an amended investment and funding pact.",
      "url": "https://finnhub.io/api/news?id=2ba4f2fb25dc0595b874194d6778bac09e387383bd9b633b9c73506c5c2277ab"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise",
    "summary": "Gilead stock rated buy for thriving HIV biz, promising oncology pipeline, and long-term growth potential despite volatility. Explore more here.",
    "url": "https://finnhub.io/api/news?id=b7581c63c89c70b91bd2e8a91ae040607d1df7fee05f079ac8312f5509195372",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735444277,
      "headline": "Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise",
      "id": 132193536,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1221948883/image_1221948883.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead stock rated buy for thriving HIV biz, promising oncology pipeline, and long-term growth potential despite volatility. Explore more here.",
      "url": "https://finnhub.io/api/news?id=b7581c63c89c70b91bd2e8a91ae040607d1df7fee05f079ac8312f5509195372"
    }
  }
]